katharina_janus_07-2017

Katharina Janus

Professor of Healthcare Management and Director of the Center for Healthcare Management, Germany, and Columbia University, New York, USA

Katharina Janus, a professor of healthcare management in Germany and at Columbia University New York, is the founder and managing director of the Center for Healthcare Management and the president of the consulting network ENJOY STRATEGY. She has twenty years of global healthcare management experience in science and corporate practice. Starting her career in managed care at one of the largest hospital chains in the United States, she has learned about challenges on the shop floor before turning to academia where she continued to pursue applied research. She then left her tenured position in Germany to lead the Center for Healthcare Management and reinvent research and education that is in constant dialogue with practice. Her global consulting network ENJOY STRATEGY supports many of the Center’s projects on the implementation side. She also serves as a member of the board at Allianz health insurance, Munich, Germany.

As a healthcare manager in research and practice she puts a strong emphasis on managing the human side of healthcare delivery in the new age of care management – formerly known as “managed care.” She has been invited frequently as a speaker and moderator to contribute her global domain expertise and in-depth knowledge of healthcare markets and trends. In this respect, she has helped major multinational companies with market access strategy and business development to facilitate on-site implementation in various cultural environments. Additionally, Prof. Janus has been involved in political advisory councils and consulting projects on a national and international level.

Dr. Janus was a 2006-07 Harkness Fellow in Health Care Policy at The Commonwealth Fund, a Rockefeller Foundation academic fellow in 2012 and a Brocher Foundation resident in 2014. She was also one of the youngest tenured professors and female board members of a DAX company appointed in Germany.

Richard Amiraian

Richard Amiraian

Director of the Primary Care Institute at the Mount Sinai Health System

Richard Amiraian, MD, serves as the Director of the Primary Care Institute at the Mount Sinai Health System. The Institute oversees the system’s numerous community-based primary care practices and works to promote the importance of and access to primary care. Board certified in internal medicine, Dr. Amiraian received his medical degree from the State University of New York at Buffalo. He completed his internship and residency training at the University of Rochester. He is leading several programs that ensure the highest quality of care is delivered throughout the Mount Sinai system. He also has a special interest in teaching medical students and residents primary care medicine.

Cedric Arcos

Cedric Arcos

Deputy CEO, French Hospital Federation, Paris, France

Deputy CEO of the French Hospital Federation, institution that, for over 100 years, gathers and represents all public hospitals in France, Cédric ARCOS is hospital director graduated from Sciences Po, French National School of Public Health and High Institute of Social Protection. He occupied different high responsibilities in French hospitals, as Human Resources Director of Universitarian hospital of Lyon and as Chief of staff of this hospital. In the French Hospital Federation, Cédric is in charge of the animation of the hospital network and of the implementation of the reform of governance, drawn by the last law of healthcare, in 2016. He is also in charge of the relations with political leaders and of strategic affairs of the federation.

Since 2012, Cédric Arcos runs a Think Tank, who try to propose systemic reforms for the French healthcare. He is also involved in the European Hospital Federation (HOPE), as the French representative.

At last, Cédric Arcos is in charge of teaching healthcare policies at Sciences Po Paris and is the author of « ethics and management », published in Paris in 2010 and of « Reforms of hospitals and Hospital reform » published in 2014.

Elisabeth Chaillet-Leforestier

Elisabeth Chaillet-Leforestier

Misum/Mistra Research Center, Stockholm School of Economics, Sweden

Graduate of Sciences Po Paris, EHESP and Stockholm School of Economics (SSE), Elisabeth is hospital director and expert on sustainable development and innovation of the healthcare sector. Due to her work about empirical evidences on global health and innovation in the healthcare industry, she has been invited to join the MISUM Research Center at SSE. She started her career as hospital director in 1995. First, she took on a position as Head of Medical Litigation and legal advisor for the Board of Greater Paris University Hospitals (AP-HP), then became Deputy Director in different hospitals from 1996 to 2007, several times she took on a position as Financing Director. In 2007, she joined the ESTHER National Public Group to lead programs for patients living with HIV/AIDS in developing countries, and handle a “South for South” Community Network between France and seven countries. She interfaced with the WHO’s Programs for Strengthening capacities of Human Resources for Health and the World Bank’s Performance Based Financing Program. She contributed to set up the WHO conferences on human resources in healthcare, bringing together more than 30 countries about the Consensus Country Mechanisms. In the aftermath, she returned to France where she contributed to AP-HP board strategic projects, forecast analyses and design the first-time hospital program for innovation streaming, called “IMOP”. From 1996 to 2016, she has taught Social and Public Policies at Sciences Po Paris. In 2016 and 2017, she contributed as an expert of the French Committee chaired by Olivier Veran on Hospital Financing Reform.

Peter M. Fleischut

Peter M. Fleischut

Chief Innovation Officer & Chief Medical Operating Officer, Presbyterian Hospital, New York, USA

Peter M. Fleischut, MD, is Chief Innovation Officer & Chief Medical Operating Officer of NewYork-Presbyterian Hospital where he is responsible for the DHK ambulatory center and enterprise integration, innovation and pharmacy. He joined NewYork-Presbyterian Hospital in 2006 and has held roles as Medical Director of the operating rooms, Deputy Quality Patient Safety Officer, Founding Director of the Center for Perioperative Outcomes, Chief Medical Information Officer and Vice Chairman for the Department of Anesthesiology.  Dr. Fleischut retains his appointment as Associate Professor of Anesthesiology. 

Peter Homberg

Peter Homberg

Partner, Head of German Life Sciences Practice, Dentons

Peter Homberg is Partner in the Dentons Frankfurt office. He specializes in IP, corporate law and M&A transactions in the Life Sciences and High-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology and medical device industry – from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences, and is also author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.

Mark Lloyd Davies

Mark Lloyd Davies

Senior Director, Government Affairs & Policy, Medical Devices EMEA and Johnson & Johnson Western Markets Lead, Brussels, Belgium

Mark is responsible for fostering a strong and constructive relationship between Johnson & Johnson Medical Devices and Consumer Medical Devices and Government institutions throughout Europe Middle East and Africa (EMEA). This includes the European Commission, Parliament and Council and involves extensive partnering with senior business leaders and government officials, policy makers and other key stakeholders.

Mark is a member of the Johnson & Johnson Medical Devices EMEA Leadership Team and Global Government Affairs & Policy Council for Medical Devices. He has worked for the Pharmaceutical, Consumer and Medical Device divisions of Johnson and Johnson since 2009, and has assumed roles of increasing responsibility in functions such as Communications, Corporate Social Responsibility and Government Affairs.

Mark holds a PhD from the University of Amsterdam, The Netherlands and BSc from the University of London, UK.

Carlos Jaime

Carlos Jaime

Country General Manager of InterSystems France and President of Digital Health Commission Medicine, Paris, France

Carlos strives to highlight InterSystems solutions and position the company as a key player of the digital transformation in the health field. By placing InterSystems as an architect of Connected Health & a GHT Solution provider, Carlos Jaime aims to promote a new vision of health, more connected, more efficient and affordable to all.

Carlos Jaime started his career at AGFA Healthcare where he led the sales functions for 10 years, and then served as Sales Director. He then spent 3 years at Toshiba Healthcare, 2 years in Dräger Medical & 4 year at Philips Healthcare France as Sales Director. Prior to joining InterSystems, Carlos was the Head of Healthcare French division of Samsung Electronics.

Carlos is graduated from an MBA at ESSEC Business School.

Burkhard Keese

Burkhard Keese

Chief Financial Officer (CFO) of Allianz Deutschland AG, Allianz Private Krankenversicherungs-AG, Allianz Versicherungs-AG and Allianz Lebensversicherungs-AG

Burkhard Keese was appointed Member of the Board of Allianz Private Krankenversicherungs-AG in 2012, next to his other CFO mandates of Germany’s largest insurer. Since then he is navigating through a fast changing landscape of health insurance driven by population ageing trends, advancing information technologies and regulatory changes. Mr. Keese is actively tackling the challenge of how to bring innovation to a traditional business and is engaged in numerous regulatory issues such as the implementation and ongoing development of Solvency II.

Next to his Board mandates as CFO, Mr. Keese also serves as a member of the insurance council of the Federal Financial Supervisory Authority (BaFin), the risk and finance committee of the German Insurance Association (GDV) as well as the Management Board of the Dr. Wolfgang Schieren Stiftung.

Mr. Keese started his career at KPMG as an auditor in Germany and Singapore. In 2004, he left KPMG as a partner to join Allianz SE in Munich as Executive Vice President and Head of Group Financial Reporting. He earned a diploma in Business Administration at the Ruhr-Universität Bochum and holds the Chartered Accountant and Certified Tax Accountant designation.

Walter Kopp

Walter C. Kopp

President, Medical Management Services, San Anselmo, CA, USA

Walter Kopp is President of Medical Management Services a healthcare executive management and advisory group specializing in the development of clinically integrated communities. This group has assisted with medical group practice management, medical group and hospital integration, physician succession planning, managed care analysis and contracting, and healthcare technology implementation in Health Systems. Services also include strategic positioning and market analysis, medical group development, contract negotiations, service line development and operations reviews.

A partial list of MMS recent clients include; Sutter Health, City of Hope Medical Group, Blue Shield of California, The Permanente Medical Group, Alta Bates Medical Group, Brown and Toland Medical Group, Hill Physicians Medical Group, Anthem/ Blue Cross of California, St Joseph Heritage Medical Foundation, Santa Rosa Memorial Hospital, Marin General Hospital, Lodi Memorial Community Clinics, Torrance Memorial Medical Center, Salinas Valley Healthcare District, Palm Drive Healthcare District, the American College of Surgeons and Cardiovascular Consultants Medical Group.

Previously, Walter was Chief Operating Officer of Menlo Clinic at Stanford University Medical Center. Walter was also Executive Director of BayCare Medical Group and Assistant VP and Director at St. Luke’s Hospital in San Francisco. In addition, he worked for large accounting firms, Alta Bates Hospital, University of Colorado Hospital, UC San Francisco, and the Ross Valley Medical Group.

Walter has served on various boards of Directors, including the National IPA Coalition, Marin Community Clinic, and the Bay Pacific Health Plan. Walter is founder and current advisor to the California eHealth Collaborative. He earned his BA degree from the University of California, Berkeley and his Masters in Health Administration from the University of Colorado.

Burak Malatyali

Burak Malatyali

Vice President, Strategic Alliances and Global Services

Burak Malatyali, Vice President, Strategic Alliances and Global Services, leads NYP’s international efforts and strategic alliance function to leverage NYP’s expertise with external organizations including providers, employers and payors domestically and internationally. Prior to joining NYP, he served as the Executive Director for J.P. Morgan Not-for-profit healthcare investment banking team exclusively focusing on strategic advisory and M&A services for various large health systems across the United States. Burak joined J.P. Morgan from Johns Hopkins Medicine (JHM) after spending 11 years there in various leadership and executive roles focusing on major critical growth, revenue diversification and expansion initiatives both on domestic and international fronts. Burak was the Vice President and Chief Operating Officer for Johns Hopkins Medicine International overseeing JHM’s joint ventures, partnerships and engagements overseas as well as JHM’s out-of-state and international patient services function in which he led a major turnaround initiative and achieved significant growth of the business line for JHM. Immediately prior to this role, as a Director for JHM’s System Development and Planning group, Burak was tasked to develop and execute strategies to grow JHM’s regional hospital and ambulatory network and led negotiations and integration with various health care institutions, physician practices and other entities as well as overseeing JHM’s affiliations with community hospitals and an urgent care network.

During his tenure at JHM, Burak served in various executive and leadership committees including JHM I.T. Executive Committee that was tasked to lead Epic implementation across JHM enterprise. Prior to JHM, Burak worked as a consultant at Accenture’s Financial Services practice in Germany and also as an analyst at Ata Invest in Istanbul, Turkey.

Étienne Minvielle

Étienne Minvielle

Professor of Management and Director of Management in Organizations, Ecole des Hautes Etudes en Santé Publique (EHESP), Paris, France

Etienne Minvielle is Professor of Management at the French School of Public Health (EHESP), University of Sorbonne Paris Cité. He holds the Chair of Management and is the Director of the Research unit, Management of HealthCare Organizations (MOS).

He received his MD from the Paris V School of medicine where he did his residency in Public Health. He also received a PhD in Management Science from the Polytechnique School, and also be graduated from the French business school, ESSEC. He spent one year at the Leonard Davis Institute, University of Pennsylvania, during his post-doctoral period. He recently became the director of the Master of Science in Health Care Management (EHESP, AP-HP, Ecole du Santé du Val-de-Grace, Paris VII).

His research seeks to understand the effect of new delivery systems (new forms of payment, patient pathways, quality improvement incentives, customized service) on healthcare performance. He has been continuously funded by the French Ministry of Health and the High Authority for Health for developing a national quality program, including quality indicators, ranking methods and paying for quality system, since 2003. He is currently the principal investigator of a cancer navigation research supported by the French Agency for Research which assesses the impact of patient portal on oral drugs’ observance. He is also the coordinator of a study sponsored by the French Agency for Health care Performance for designing a composite score of hospital performance (based on the medico-administrative database named Hospidiag). His research has been published in high-impact peer-reviewed journals (The BMJ, Medical Care, Social Science and Medicine, Public Administration review, International Journal of production economics).

He serves on numerous expert panels advising policy makers and government officials on the use of quality improvement incentives in health care. In addition to his research, Etienne Minvielle is also advisor at Gustave Roussy, a leading European Cancer center, for implementing innovative patient pathways. He works closely with the CEO and the board of directors to help design innovative patient pathways.

Angelo Moesslang

Angelo Moesslang

Former Chief Financial Officer, Fresenius Medical Care North America, USA

Angelo Moesslang is Chief Financial Officer of Fresenius Medical Care North America. He relocated to the Boston area from his native Germany in 2010.

He began his career with Fresenius Medical Care in Germany in 1995, and held a variety of positions, including: Head of Investor Relations, Vice President of Business Development Asia Pacific based in Hong Kong, and most recently, Chief Financial Officer Europe, Africa, Middle East, Latin America.

Prior to joining Fresenius, Angelo served as a scientific assistant to the faculty of Business Administration of the University of Stuttgart Hohenheim. He holds a Doctorate in Business Administration from University Stuttgart Hohenheim, and a Graduate Degree in Economics from Ludwigs-Maximilians University in Munich.

Simeon Schwartz

Simeon Schwartz

CEO at Optum Practice Partners, Purchase, New York, USA

Dr. Schwartz is CEO of Optum Practice Partners (OPP) a physician management services company which was formed in 2011 and acquired by Optum in 2014. He is based in London and is responsible for Optum initiatives in the UK focusing on General Practice Development and New Models of Care.

Dr. Schwartz is also the founder and President of WESTMED Medical Group (WMG) which was formed in 1996. Since its founding, the multi-specialty medical group has grown to over 350 physicians with 10 locations in Westchester County, New York and Fairfield CT. WMG embraced the Triple Aim and is proud to have transitioned to value-based care with a successful ACO and strong results for quality efficiency and service.

Throughout his medical career, Dr. Schwartz has been committed to improving the health of the community by providing coordinated, efficient, quality patient care. To accomplish this goal, he and his team were early adopters of healthcare IT, collaborating with many innovative IT vendors in the areas of process and system redesign to improve care. OPP has continued to focus on lean ambulatory healthcare transformation. Improvements in both operational and clinical efficiency were achieved with analytically-based work flow redesign facilitated by extensive use of automated rules and tasking engines.

As Optum Practice Partners grows and evolves, Dr. Schwartz defines its collaborative culture as one that drives efficiency and value – necessary attributes for the modern physician practice to be the best place for patients to receive care, the best place for physicians to practice medicine, and the best place for employees to work.

Dr. Schwartz received his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from Yale University School of Medicine in New Haven. Dr. Schwartz then completed his internship and residency at The New York Hospital-Cornell Medical Center and a fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center.

Medical Specialties: Dr. Schwartz is a board certified hematologist and oncologist with board certification in internal medicine, medical oncology, hematology and blood banking.

Nedal Shami

Nedal Shami

MD, Chief Strategy Officer, CityMD, New York, USA

Dr. Nedal Shami is a board certified emergency medicine physician and a co-founder of CityMD Urgent Care. He serves as the Chief Strategy Officer and previously served as Chief Operations Officer since the company’s inception in 2010 through 2014. He has served on the CityMD Board of Directors since 2013. CityMD is a service oriented, patient-focused, high quality provider of medical care that has redefined the consumer healthcare experience. The company has more than 250 physicians with over 60 practices in the New York metro area, and is actively expanding to several west coast markets. Dr. Shami responsibilities and focus have been on all aspects of strategic expansion, during which time the company experienced exponential unit and volume growth reaching a total market penetration of nearly one third of the metropolitan population.

In his professional career, Dr. Shami has served in several academic and administrative roles, with appointments at both Saint Luke’s-Roosevelt Hospital and The Valley Hospital. He continues to serve as an associate professor at New York Presbyterian-Weill Cornell Medical Center.

Dr. Shami received his Bachelor’s degree from New York University and went on to obtain his medical degree at University College Dublin, graduating with Cum Laude Honors.  He completed his internship in Internal Medicine at Montefiore Medical Center in New York and went on to complete his residency in Emergency Medicine at North Shore-LIJ/Albert Einstein College of Medicine, where he was the Chief Resident. Dr. Shami is passionate about service to charitable organizations, participating frequently in medical missions to developing countries. In 2011, he traveled to Haiti to lead a medical team following a devastating earthquake. He received the Hero of Haiti award on behalf of The Valley Health System. Dr. Shami lives in NYC with his wife and two children.

Gabriela Soskuty

Gabriela Soskuty

Senior Vice President Global Government Affairs & Market Access, B. Braun Melsungen AG, Berlin, Germany

Since 2007, Gabriela Soskuty is responsible for Global Government Affairs & Market Access at B. Braun Melsungen AG, most recently as Senior Vice President. A doctor by training, Dr. Soskuty practiced in Obstetrics and Gynecology before moving into the medical device market, where she has held positions in clinical affairs, marketing, market access and policy development at Hill-Rom, Boston Scientific and Johnson & Johnson.

She is actively involved in industry working groups on health policy, funding and re¬imbursement and HTA, holds the chair of the BVMed Market Access working group and is a frequent speaker at events, offering her in-depth knowledge of the medical device market access mechanisms. She has served on the board of the German Association of Health Economists and the Society for Market Access, as a member of the Health Research Advisory Board of the German Ministry of Education and Research and on a number of other advisory boards. She is also a member of various cross-sectoral initiatives dedicated to improving the health economy in Germany.

Michael Sparer

Michael S. Sparer

Professor and Chair Department of Health Policy and Management Mailman School of Public Health, Columbia University, NY, USA

Dr. Michael S. Sparer is Professor and Chair in the Department of Health Policy and Management at the Mailman School of Public Health at Columbia University. Professor Sparer studies and writes about the politics of health care, with a particular emphasis on the health insurance and health delivery systems for low-income populations, and the ways in which inter-governmental relations influences policy. He is a two-time winner of the school’s Student Government Association Teacher of the Year Award, as well as the recipient of the 2010 Presidential Award for Outstanding Teaching. Professor Sparer spent seven years as a litigator for the New York City Law Department, specializing in inter-governmental social welfare litigation. After leaving the practice of law, Sparer obtained a Ph.D. in Political Science from Brandeis University. Sparer is the editor of the Journal of Health Politics, Policy and Law, and the author of Medicaid and the Limits of State Health Reform, as well as numerous articles and book chapters.

Brent Stackhouse

Brent Stackhouse

Vice President, Mount Sinai Health System, New York, USA

Brent Stackhouse is the Vice President of Mount Sinai Ventures for the Mount Sinai Health System in New York City.  His responsibilities include diversifying the portfolio of strategic investments to enhance Mount Sinai’s transition to population health management.  He currently serves on the Board of Directors, or works with over a dozen companies including ambulatory surgery and urgent care centers.  He is experienced in public health and health information technology, and serves on Mount Sinai telehealth strategy committee, the Junto Collaborative for health innovation, and is a mentor for the Blueprint Health technology incubator.

Prior to joining Mount Sinai, Brent was the Executive Director of Strategy at the Primary Care Information Project at the New York City Department of Health and Mental Hygiene.   In this role, Brent oversaw the strategy and operations for the bureau responsible for expanding the adoption of electronic health records and the use of health information technology for care coordination and quality improvement.  He was responsible for developing and managing programs for key stakeholders including Accountable Care Organizations, health systems, insurance companies, as well as State and Federal partners.

Prior to his career in health care, Brent worked in investment banking and commercial real estate finance. He has a Bachelor in Science from the Walsh School of Foreign Service at Georgetown University.